Global Vaccine Research Market 2022-2026

Global Vaccine Research Market 2022-2026

Technavio has been monitoring the vaccine research market and it is poised to grow by $ 13.34 bn during 2022-2026, accelerating at a CAGR of 8.36% during the forecast period. Our report on the vaccine research market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by high prevalence of infectious diseases,need for novel vaccines for chronic infections, and rise in the funding for the R and D of COVID-19 vaccines.

The vaccine research market analysis includes the end-user segment and geographic landscape.

Technavio's vaccine research market is segmented as below:

By End-user

• Public
• Private

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the adoption of AI to speed up the R and D of vaccines as one of the prime reasons driving the vaccine research market growth during the next few years. Also, fluctuations in demand for vaccines in high-income and developing countries and rising R and D of novel vaccines will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on vaccine research market covers the following areas:

• Vaccine research market sizing
• Vaccine research market forecast
• Vaccine research market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaccine research market vendors that include Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd. Also, the vaccine research market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.